Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)-Reference-Cited by-同舟云学术

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)

Published:2018-01 Issue:1 Volume:9 Page:24-31
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

McCleary Nadine J.,Hubbard Joleen,Mahoney Michelle R.,Meyerhardt Jeffrey A.,Sargent Daniel,Venook Alan,Grothey Axel

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference22 articles.

1. Preface;Rao;Clin Geriatr Med,2016

2. PRODIGE 20: bevacizumab+chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)--a randomized phase II trial;Aparicio;ASCO Meet Abstr,2015

3. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients;Aparicio;J Clin Oncol,2013

4. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial;Cunningham;Lancet Oncol,2013

5. Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of capecitabine, bevacizumab and mitomycin C;Price;Ann Oncol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018);Journal of Clinical Oncology;2024-08-26

2. Clinical trials in older patients with cancer – typical challenges, possible solutions, and a paradigm of study design in breast cancer;Acta Oncologica;2024-06-17

3. Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation;Journal of Clinical Oncology;2023-12-01

4. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis;Journal of Geriatric Oncology;2022-05

5. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions;CA: A Cancer Journal for Clinicians;2020-10